No matter how small the risk that Constellation will see its own growth stymied by regulatory interference, the stock currently costs nearly 29 times forecast 2024 earnings of $8 to $8.40 per share.
Quarterly Revenue Growth of 1.9%, driven by continued strong growth in the International segment Quarterly Net Income of $6.4 million, or $0.20 per diluted share Quarterly Adjusted EBITDA (non-GAAP) ...
Overall net sales rose 2.6% to $2.86 billion in the second quarter, while net income soared to more than $299 million, a staggering 1,380% increase from a year ago. Its Autoship sales -- recurring ...
Good day, and welcome to the S&W Seed Fourth Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation, there will be an ...
LOUISVILLE, Colo., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced its financial and operating results for the third quarter ...
Atlassian Corporation (NASDAQ: TEAM), a leading provider of team collaboration and productivity software, today announced financial results for its fi ...
Revenue of $2.6 billion, up 3% on an as-reported and FX-Neutral basis Gross Merchandise Volume of $18.3 billion, up 2% on an as-reported basis and up 1% on an FX-Neutral ...